Carvedilol
USP/1096622 - United States Pharmacopeia (USP) Reference Standard
Synonym: 1-
CAS Number: 72956-09-3
Empirical Formula (Hill Notation): C24H26N2O4
Molecular Weight: 406.47
MDL Number: MFCD00864692
Linear Formula: C24H26N2O4
Product Type: Chemical
| API family | carvedilol |
| application(s) | pharmaceutical (small molecule) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C24H26N2O4/c1-28-21-10 |
| InChI key | OGHNVEJMJSYVRP-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | OC(COC1=CC=CC2=C1C3=C(C=C |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Carvedilol USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Carvedilol Tablets |
| Biochem/physiol Actions: | Cavedilol is a non-selective β-adrenergic blocker with α1 blocking activity. |
| Biochem/physiol Actions: | Cavedilol is a non-selective β-adrenergic blocker with α1 blocking activity. Carvedilol is used specifically for the treatment of heart failure and high blood pressure. It has been shown to improve left ventricular ejection fraction and may reduce mortality. |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia ![]() |
| Other Notes: | Sales restrictions may apply. |
| Symbol | GHS09 |
| Hazard statements | H411 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |


